Better understanding of pathogenesis and predictability of Type 1 diabetes also creates perspectives for disease prevention. Collaborative efforts of national registries provide the methodology of choice to assess the effectiveness of proposed pharmacological or immunologica...
Insulin pump therapy for type 1 diabetes 来自 ProQuest 喜欢 0 阅读量: 11 作者: Jacobs, Philip 摘要: Author information: (1)Diabetes Research Group, Division of Diabetes and Nutritional Sciences, King's College London School of Medicine and Guy's Hospital, London, United Kingdom. john.pick...
Type 1 diabetes doesn’t take a break. But managing your insulin therapy with Omnipod can give you one. Omnipod 5 is indicated for people with type 1 diabetes, ages 2+. Omnipod for Type 1 Type 2 diabetes (insulin-requiring) If you feel like type 2 diabetes is taking control of your...
Type 1 diabetes doesn’t take a break. But managing your insulin therapy with Omnipod can give you one. Omnipod 5 is indicated for people with type 1 diabetes, ages 2+. Omnipod for Type 1 Type 2 diabetes (insulin-requiring) If you feel like type 2 diabetes is taking control of your...
[Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes] This study's aim was to project the long-term clinical and economic outcomes of continuous subcutaneous insulin infusion (CSII) treatment compared to multi... K Nørgaard,A Sohlberg,G Goodall - 《Ugesk...
Type 1 insulin-like growth factor receptor (IGF1R) is a receptor tyrosine kinase that regulates cell growth and proliferation, and can be activated by IGF1, IGF2, and insulin. Here, we report the cryo-EM structure of full-length IGF1R–IGF1 complex in the active state. This structure rev...
Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002; 141 (4):490–495. J Litton,A Rice,N Friedman,... - 《Journal of Pediatrics》 被引量: 287发表: 2002年 Insulin-pump therapy for type 1 diabetes mellitus to the editor: In his review...
Type II IGF receptor (IGF-IIR), however, lacks intrinsic kinase activity and negatively regulates circulating and local levels of IGF-II by targeting it to lysosomes for degradation, thereby acting as a growth inhibitor [15]. InsR or IGF-IR exists in dimer. In addition, a half InsR and ...
The target glycated hemoglobin A1c (HbA1c) for all children with type 1 diabetes mellitus (T1DM), including preschool children, is recommended to be < 7.5% (< 58 mmol/mol)(Grade B, EL I) Show more Long-Term Glycemic and Metabolic Control ...
BACKGROUND: Basal and bolus insulin determination in intensive insulin therapy for type 1 diabetes mellitus (T1DM) are currently considered independently of each other. A new strategy that coordinates basal and bolus insulin infusion to cope with postprandial glycemia in pump therapy is proposed. Supe...